Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study.
暂无分享，去创建一个
D. Isenberg | M. Rotte | W. Ng | S. Bowman | P. Gergely | A. Papas | S. Carsons | D. Kyburz | A. Kivitz | M. Bombardieri | F. Barone | H. Hockey | B. Fisher | A. Szántó | A. Wright | P. Espié | M. Posch | J. Rush | T. Daikeler | B. Bannert | C. Dupuy | J. Milojevic | A. Avrameas | A. Farag | D. Floch | Xiaohui Ren | P. Faerber | M. Valentin | P. Espié | S. Bowman | Cyrielle Dupuy